Ratings by Chardan (Taylor Feehley)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 2/9/2024 | Synlogic Inc. | SYBX | Downgrade | Neutral (Buy) |
3.45 (0.56) |
-83.77% | Details | |
| 6/6/2023 | Synlogic Inc. | SYBX | Maintain | Buy (N/A) |
|
Details | ||
| 3/30/2023 | Synlogic Inc. | SYBX | Maintain | Buy (N/A) |
|
Details | ||
| 9/18/2020 | Seres Therapeutics | MCRB | Downgrade | Neutral (Buy) |
26.86 (18.11) |
-32.58% | Details | |
| 8/10/2020 | Seres Therapeutics | MCRB | Maintain | Buy (N/A) |
|
Details | ||
| 8/20/2019 | Synlogic Inc. | SYBX | Maintain | Buy (N/A) |
|
Details | ||
| 7/15/2019 | Synlogic Inc. | SYBX | Maintain | Buy (N/A) |
|
Details | ||
| 6/10/2019 | Provention Bio Inc. | PRVB | New Coverage | Buy (N/A) |
4.35 (24.98) |
474.25% | Details | |
| 4/23/2019 | Kaleido Biosciences Inc. | KLDO | New Coverage | Buy (N/A) |
14.78 (0.00) |
-100% | Details | |
| 3/11/2019 | Spring Bank Pharmaceuticals | SBPH | Maintain | Buy (N/A) |
|
Details | ||
| 1/29/2019 | Evelo Biosciences Inc | EVLO | New Coverage | Neutral (N/A) |
8.62 (0.00) |
-100% | Details | |
| 12/13/2018 | Synlogic Inc. | SYBX | New Coverage | Buy (N/A) |
7.36 (0.56) |
-92.39% | Details | |
| 10/22/2018 | Seres Therapeutics | MCRB | New Coverage | Buy (N/A) |
6.62 (7.01) |
5.89% | Details |
